Advanced Blood and Marrow Transplant Surgeries
Our Blood and Marrow Transplant Program is conducted in conjunction with the Rutgers Cancer Institute. The physician and medical teams that focus on blood and marrow transplants perform stem cell transplants for patients with a variety of illnesses, including:
- Acute and chronic leukemias
- Myelodysplasia
- Lymphoma
- Hodgkin's disease
- Multiple myeloma
- Amyloidosis and related diseases
When it comes to stem cell transplants, both autologous and allogeneic transplants are performed.
Autologous transplants are when cells are harvested from the patient's bone marrow before chemotherapy and are replaced after cancer treatment.
Allogeneic transplants are when stem cells come from a donor whose tissue most closely matches the patient, like a child, sibling or parent.
Additional sources of transplant include matched unrelated donors and umbilical cord blood.
With this program, patients have access to clinical trials, state-of-the art technology, disease specific specialists—including the area’s best hematologic pathologists—and a full line of support services: social workers, dieticians, support groups, on-site pharmacy, and financial counselors.
Blood and Marrow Transplant Research
There are several research initiatives within the our Blood and Marrow Transplant Program. In addition to participating in national and international clinical research studies with other transplant centers, there are unique research programs focusing on novel ways to:
- Prevent graft-versus-host disease
- Improve umbilical cord blood transplants
- Develop novel cellular therapies with less toxicity than standard transplants
The program is certified by the Foundation for the Accreditation of Cellular Therapy (FACT) as well as the National Marrow Donor Program.